Milestone Scientific Company Profile (AMEX:MLSS)

About Milestone Scientific (AMEX:MLSS)

Milestone Scientific logoMilestone Scientific Inc. (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types. Milestone's product portfolio includes Single Tooth Anesthesia Instrument (STA Instrument), CompuDent, CompuMed and The Wand. The Company's STA Instrument is a computer-controlled local anesthesia delivery instrument that utilizes the pressure feedback elements of Milestone's CompuFlo technology. CompuDent (also known as the Wand Plus internationally) is Milestone's C-CLAD instrument. CompuMed is a computer-controlled injection instrument offered by the Company. The Wand handpiece is used in conjunction with the STA, CompuDent and CompuMed instruments.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Supplies
  • Sub-Industry: N/A
  • Symbol: AMEX:MLSS
  • CUSIP: N/A
  • Web:
Average Prices:
  • 50 Day Moving Avg: $1.33
  • 200 Day Moving Avg: $1.40
  • 52 Week Range: $1.08 - $2.67
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -27.50
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $10.86 million
  • Price / Sales: N/A
  • Book Value: $0.23 per share
  • Price / Book: 4.78
  • EBIDTA: ($5,380,000.00)
  • Net Margins: -14.46%
  • Return on Equity: -23.73%
  • Return on Assets: -16.66%
  • Average Volume: 32,744 shs.
  • Short Ratio: 0.87

Frequently Asked Questions for Milestone Scientific (AMEX:MLSS)

What is Milestone Scientific's stock symbol?

Milestone Scientific trades on the AMEX under the ticker symbol "MLSS."

Where is Milestone Scientific's stock going? Where will Milestone Scientific's stock price be in 2017?

1 equities research analysts have issued twelve-month price targets for Milestone Scientific's stock. Their predictions range from $4.00 to $4.00. On average, they expect Milestone Scientific's share price to reach $4.00 in the next year. View Analyst Ratings for Milestone Scientific.

Who are some of Milestone Scientific's key competitors?

Who are Milestone Scientific's key executives?

Milestone Scientific's management team includes the folowing people:

  • Leslie Bernhard, Independent Chairman of the Board
  • Daniel S. Goldberger, President, Chief Executive Officer
  • Joseph D'Agostino, Chief Financial Officer, Chief Operating Officer
  • Gian Domenico Trombetta, President and Chief Executive Officer - Dental Division, Director
  • James McAvinn, Senior Vice President - Sales & Marketing
  • Leonard A. Osser, Director
  • Edward J. Zelnick M.D., Director
  • Leonard M. Schiller, Independent Director
  • Pablo Felipe Serna Cardenas, Independent Director

How do I buy Milestone Scientific stock?

Shares of Milestone Scientific can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Milestone Scientific's stock price today?

One share of Milestone Scientific stock can currently be purchased for approximately $1.10.

MarketBeat Community Rating for Milestone Scientific (AMEX MLSS)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  14 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  25
MarketBeat's community ratings are surveys of what our community members think about Milestone Scientific and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Milestone Scientific (AMEX:MLSS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.00

Analysts' Ratings History for Milestone Scientific (AMEX:MLSS)
DateFirmActionRatingPrice TargetDetails
6/13/2017Maxim GroupReiterated RatingBuy$4.00View Rating Details
(Data available from 8/22/2015 forward)


Earnings History for Milestone Scientific (AMEX:MLSS)
No earnings announcements for this company have been tracked by


Earnings Estimates for Milestone Scientific (AMEX:MLSS)
Current Year EPS Consensus Estimate: $-0.15 EPS
Next Year EPS Consensus Estimate: $-0.04 EPS


Dividend History for Milestone Scientific (AMEX:MLSS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Milestone Scientific (AMEX:MLSS)
No insider trades for this company have been tracked by


Headline Trends for Milestone Scientific (AMEX:MLSS)
Latest Headlines for Milestone Scientific (AMEX:MLSS)
DateHeadline logoMilestone Scientific Announces First Patient Treated with CompuFlo(R) Epidural Instrument at University of Miami Hospital - August 9 at 12:25 AM logoMilestone Scientific Launches New User-Friendly, Multi-Platform Compatible Website - July 28 at 4:17 PM logoMary Kay Launches Beauty Industry First As Thousands Convene For U.S. Seminar - July 21 at 9:37 PM logoMilestone Scientific Inc. (MLSS) Earns Buy Rating from Maxim Group - June 18 at 3:02 PM logoMilestone Scientific Announces 510(k) FDA Clearance for CompuFlo(R) Epidural Instrument - June 12 at 9:19 AM logoMilestone Scientific Hosts Webcast with U.S. Key Opinion Leader to Discuss Advantages of the Wand(R) Dental Instrument - May 24 at 10:42 AM logoMilestone Scientific Hosts Webcast with Top Key Opinion Leader to Discuss Advantages of the CompuFlo(TM) Epidural Instrument - May 19 at 11:13 AM logoMilestone Scientific Reports 53% Increase in Handpiece Sales Attributable to USA and Canada for the First Quarter of 2017 - May 15 at 5:56 PM logoMilestone Scientific Schedules First Quarter 2017 Earnings Conference Call - May 15 at 8:01 AM logoMilestone Pharmaceuticals Announces Etripamil Phase 2 Clinical Program Success for the Treatment of Paroxysmal Supraventricular Tachycardia - May 13 at 8:50 AM logoMilestone Scientific Announces Regulatory Marketing Clearance to Sell Epidural Instruments and Disposables in Saudi Arabia - April 19 at 10:32 AM logoMilestone Scientific, Inc. :MLSS-US: Earnings Analysis: 2016 By the Numbers : April 11, 2017 - April 11 at 11:13 AM logoQ4 2016 Milestone Scientific Inc Earnings Release - Time Not Supplied - April 3 at 5:51 PM logoMilestone Scientific Reports 10% Increase in Revenue for Fiscal 2016 - April 3 at 5:51 PM logoMilestone Scientific Schedules 2016 Year-End Earnings Conference Call - March 31 at 6:40 PM


Social activity is not available for this stock.
This page was last updated on 8/22/2017 by Staff